AMRX - Amneal Pharmaceuticals, Inc.

13.24
-0.020   -0.151%

Share volume: 1,550,712
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$13.26
-0.02
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-08-2024 08-09-2024 11-12-2024 02-28-2025 05-07-2025 08-07-2025 11-06-2025
Total revenue 659.191 M 701.780 M 702.468 M 730.518 M 695.420 M 724.508 M 784.513 M
Cost of revenue 421.131 M 451.833 M 432.910 M 467.645 M 439.529 M 438.255 M 510.539 M
Gross profit 238.060 M 249.947 M 269.558 M 262.873 M 255.891 M 286.253 M 273.974 M
    4.99% 7.85% -2.48% -2.66% 11.87% -4.29%  
Operating expenses 151.893 M 152.516 M 179.789 M 188.797 M 160.095 M 174.247 M 203.604 M
Selling general and admin 112.595 M 116.462 M 118.692 M 128.687 M 118.288 M 124.266 M 137.815 M
Research and development 39.298 M 36.054 M 61.097 M 60.110 M 41.807 M 49.981 M 65.789 M
Total expenses 248.806 M 154.477 M 180.749 M 187.080 M 155.544 M 174.881 M 203.630 M
    -37.91% 17.01% 3.50% -16.86% 12.43% 16.44%  
Operating income -10.746 M 95.470 M 88.809 M 75.793 M 100.347 M 111.372 M 70.344 M
Ebit -9.819 M 86.124 M 80.934 M 46.343 M 94.425 M 116.812 M 88.956 M
Pretax income -75.522 M 20.405 M 15.423 M -15.319 M 37.486 M 51.711 M -5.223 M
    -127.02% -24.42% -199.33% -344.70% 37.95% -110.10%  
Income tax 6.156 M 3.618 M 3.666 M 5.423 M 12.868 M 16.101 M -23.355 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -81.678 M 16.787 M 11.757 M -20.742 M 24.618 M 35.610 M 18.132 M
    120.55% -29.96% -276.42% 218.69% 44.65% -49.08%